tiprankstipranks
Trending News
More News >
Shenguan Holdings (Group) Limited (HK:0829)
:0829
Hong Kong Market

Shenguan Holdings (Group) Limited (0829) AI Stock Analysis

Compare
0 Followers

Top Page

HK

Shenguan Holdings (Group) Limited

(0829)

Rating:58Neutral
Price Target:
Shenguan Holdings' overall stock score is driven by a stable balance sheet but hindered by inconsistent financial performance and operational inefficiencies. Technical indicators suggest limited momentum, and while the valuation shows a high P/E ratio suggesting potential overvaluation, the high dividend yield could be appealing. The lack of recent earnings call and corporate events data limits further analysis.

Shenguan Holdings (Group) Limited (0829) vs. iShares MSCI Hong Kong ETF (EWH)

Shenguan Holdings (Group) Limited Business Overview & Revenue Model

Company DescriptionShenguan Holdings (Group) Limited, an investment holding company, manufactures and sells edible collagen sausage casing products in Mainland China, rest of Asia, and internationally. It also manufactures pharmaceutical products and intermediates, food products, skin care and health care products, bioactive collagen products, and fine chemicals for human usage. The company was incorporated in 2009 and is headquartered in Causeway Bay, Hong Kong. Shenguan Holdings (Group) Limited is a subsidiary of Rich Top Future Limited.
How the Company Makes MoneyShenguan Holdings generates revenue primarily through the production and sale of edible collagen sausage casings. The company leverages its advanced manufacturing technology and expertise in collagen processing to produce high-quality casings used by food manufacturers worldwide. Its revenue model is largely driven by sales to sausage producers, who require consistent and reliable casings for their products. Additionally, Shenguan Holdings may engage in strategic partnerships or collaborations to enhance its market reach and product offerings, although specific partnerships are not detailed. The company's earnings are influenced by factors such as raw material costs, production efficiency, and demand fluctuations in the global food processing industry.

Shenguan Holdings (Group) Limited Financial Statement Overview

Summary
Shenguan Holdings shows a stable balance sheet with low leverage, but income statement challenges with inconsistent revenue and declining margins. Cash flow generation has been concerning, particularly with zero operating cash flow recently.
Income Statement
62
Positive
The income statement shows a mixed performance. Gross profit margin has decreased over recent years, and the net profit margin has seen fluctuations. Revenue growth has been inconsistent, with a decline in 2024 compared to 2023. EBIT margin is low and even negative in some years, indicating potential operational inefficiencies. However, EBITDA margin remains relatively stable, suggesting some underlying operational strength.
Balance Sheet
78
Positive
The balance sheet is relatively strong with a low debt-to-equity ratio, indicating conservative leverage. The company maintains a high equity ratio, reflecting stability and a solid asset base. Return on equity has been declining, which is a concern, but overall, the company maintains financial resilience with substantial cash reserves.
Cash Flow
55
Neutral
Cash flow performance has been uneven. Operating cash flow was zero in the latest year, indicating potential issues in generating cash from operations. Free cash flow has fluctuated and shows low growth, with no positive trend. The high operating cash flow to net income ratio in previous years indicates good cash generation relative to profits, but recent performance is concerning.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
1.02B1.11B1.03B1.17B961.62M
Gross Profit
171.08M170.86M160.47M310.49M239.05M
EBIT
1.12M-5.51M-15.44M117.66M51.83M
EBITDA
90.44M178.00M79.11M211.95M186.65M
Net Income Common Stockholders
26.66M31.24M23.57M122.65M90.75M
Balance SheetCash, Cash Equivalents and Short-Term Investments
503.80M824.01M953.95M998.90M717.28M
Total Assets
2.83B2.96B3.35B3.31B3.13B
Total Debt
247.97M277.37M540.73M427.95M151.25M
Net Debt
-255.83M-746.59M-413.23M-570.95M-566.03M
Total Liabilities
536.49M581.08M834.97M656.48M441.48M
Stockholders Equity
2.30B2.38B2.52B2.66B2.69B
Cash FlowFree Cash Flow
0.0093.98M34.24M110.55M367.03M
Operating Cash Flow
0.00176.45M106.04M179.71M443.14M
Investing Cash Flow
0.00298.11M44.80M-212.22M-406.53M
Financing Cash Flow
0.00-455.19M-71.04M104.16M-116.79M

Shenguan Holdings (Group) Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.28
Price Trends
50DMA
0.27
Positive
100DMA
0.27
Positive
200DMA
0.26
Positive
Market Momentum
MACD
<0.01
Negative
RSI
71.94
Negative
STOCH
-60.00
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0829, the sentiment is Positive. The current price of 0.28 is above the 20-day moving average (MA) of 0.28, above the 50-day MA of 0.27, and above the 200-day MA of 0.26, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 71.94 is Negative, neither overbought nor oversold. The STOCH value of -60.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0829.

Shenguan Holdings (Group) Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$8.89B15.044.68%6.15%3.59%-2.51%
58
Neutral
HK$904.53M31.461.14%14.29%-10.03%-14.29%
$127.30B6.26
7.39%
$10.87B46.276.14%1.22%
$12.94B19.7313.20%2.55%
DE640
€3.73B8.54
2.97%
58
Neutral
HK$30.77B73.882.29%24.36%-18.99%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0829
Shenguan Holdings (Group) Limited
0.28
0.04
16.67%
PIAIF
Ping An Insurance Company of China
6.19
1.81
41.32%
SBMFF
Sino Biopharmaceutical
0.73
0.38
108.57%
CHJTF
CSPC Pharmaceutical Group
1.01
0.18
21.69%
DE:640
China Resources Pharmaceutical Group Ltd.
0.58
-0.08
-12.12%
HK:1060
Alibaba Pictures Group Limited
1.03
0.56
119.15%

Shenguan Holdings (Group) Limited Corporate Events

Shenguan Holdings Announces AGM with Key Resolutions on Dividends and Share Issuance
Apr 29, 2025

Shenguan Holdings (Group) Limited has announced its upcoming annual general meeting scheduled for June 6, 2025. Key resolutions to be discussed include the approval of a final and special dividend for the year ended December 31, 2024, reappointment of Ernst & Young as auditors, and re-election of several directors. Additionally, the company seeks authorization to issue additional shares and securities, which could potentially impact its market positioning and shareholder value.

Shenguan Holdings Reports Decline in 2024 Financial Results
Mar 24, 2025

Shenguan Holdings (Group) Limited announced its annual financial results for the year ended December 31, 2024, reporting a decrease in revenue by 8.4% to RMB 1,016.8 million and a 14.7% drop in profit attributable to owners of the parent. Despite the decline in financial performance, the company maintained its dividend payouts, proposing a final dividend of HK2.0 cents per share and a special final dividend of HK2.0 cents per share. The results reflect challenges in the company’s operational efficiency, as seen in increased inventory turnover days and reduced trade payables turnover days, which may impact its market positioning and stakeholder confidence.

Shenguan Holdings Announces Final Dividend for 2024
Mar 24, 2025

Shenguan Holdings (Group) Limited has announced a final cash dividend of HKD 0.02 per share for the financial year ending December 31, 2024. This announcement reflects the company’s financial performance and its commitment to returning value to shareholders, with the dividend payment scheduled for July 9, 2025, following shareholder approval in June.

Shenguan Holdings Declares Special Final Dividend for 2024
Mar 24, 2025

Shenguan Holdings (Group) Limited has announced a special final dividend of HKD 0.02 per share for the financial year ending December 31, 2024. The dividend is set to be approved by shareholders on June 6, 2025, with the payment scheduled for July 9, 2025. This announcement reflects the company’s financial strategy and its commitment to returning value to shareholders.

Shenguan Holdings Announces Director Retirement
Mar 24, 2025

Shenguan Holdings (Group) Limited has announced that Mr. Ru Xiquan, an executive director, will retire by rotation and will not seek re-election at the upcoming annual general meeting scheduled for June 2025. Mr. Ru has confirmed no disagreements with the board, and the company expressed gratitude for his contributions, indicating a smooth transition without any immediate impact on the company’s operations or stakeholder relations.

Shenguan Holdings Schedules Board Meeting to Approve Annual Results
Mar 12, 2025

Shenguan Holdings (Group) Limited has announced a board meeting scheduled for March 24, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the potential payment of a final dividend, which could impact shareholder returns and reflect the company’s financial health.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.